Notice to Employees of AstraZeneca Pharmaceuticals LP and AstraZeneca LP

This document is about a notice to employees of AstraZeneca Pharmaceuticals LP and AstraZeneca LP regarding their application to the U.S. Department of Labor for authorization under Prohibited Transaction Exemption 96-62 to allow the reinsurance of risks and receipt of premiums by a captive insurance company, AZ-Mont Insurance Company, from insurance contracts funding the AstraZeneca Life and AD&D Plan. The notice outlines the proposed transaction, the parties involved, the changes to the plan benefits, and the employee's right to comment on the tentative authorization.